MA S779

Health insurers, pharmacy benefit managers, and third-party payors are prohibited from reimbursing 340B entities at lower rates than non-340B pharmacies for the same drugs, or imposing discriminatory fees, clawbacks, or dispensing fees

Insurers and PBMs cannot exclude 340B entities from pharmacy networks, require 340B-specific billing modifiers, or impose additional data reporting requirements solely because an entity participates in the federal 340B drug discount program

Drug manufacturers and distributors are prohibited from denying, restricting, or interfering with the delivery of 340B drugs to contracted pharmacies authorized to dispense on behalf of covered entities

Protections apply across multiple insurance types including the Group Insurance Commission, commercial insurers, Blue Cross Blue Shield plans, HMOs, and nonprofit hospital service corporations

Exemptions exist for Medicaid fee-for-service reimbursements and for data requirements mandated by CMS, HHS, or the Massachusetts Division of Medical Assistance